Abiopharma

📋 DOUGLAS J MILANES (Officer) plans to sell 4K shares of DARDEN RESTAURANTS, INC. (at $202.16 each, total $732K) Filed: Apr 17, 2026 | ID: 003584

📋 George Kurtz (President, CEO) plans to sell 155K shares of Crowdstrike Holdings, Inc. (at $418.20 each, total $64.8M) Filed: Apr 17, 2026 | ID: 000369

Director BLANK DONNA 🟢 acquired 17.0K shares of AGNC Investment Corp. (AGNC) Transaction Date: Apr 16, 2026 | Filing ID: 000090

Lisowski Craig 🟡 adjusted position in 128.3K shares (3 derivative) of Nextdoor Holdings, Inc. (NXDR) at $1.52 Transaction Date: Apr 15, 2026 | Filing ID: 000087

Director Goldstein Jeffrey A 🟢 acquired 1.2K shares of Fidelity National Information Services, Inc. (FIS) at $47.39 Transaction Date: Apr 15, 2026 | Filing ID: 025718

Ponnambalam Indrajit 🟡 adjusted position in 34.2K shares (1 derivative) of Nextdoor Holdings, Inc. (NXDR) at $1.52 Transaction Date: Apr 15, 2026 | Filing ID: 000086

New Clinical and Preclinical Data for Investigational Candidate Zidesamtinib Presented at AACR Annual Meeting 2026

VALUE LINE, INC. DIVIDEND HAS JUST BEEN RAISED FROM $1.30 TO $1.40 (ANNUALIZED) – ITS 12TH CONSECUTIVE INCREASE

Director FISK JOHN D 🟢 acquired 17.0K shares of AGNC Investment Corp. (AGNC) Transaction Date: Apr 16, 2026 | Filing ID: 000088

New Form 4/A - Pennant Group, Inc. <b>Filed:</b> 2026-04-17 <b>AccNo:</b> 0001766400-26-000045 <b>Size:</b> 7 KB

Director Tolia Nirav N 🟡 adjusted position in 184.5K shares (3 derivative) of Nextdoor Holdings, Inc. (NXDR) at $1.52 Transaction Date: Apr 15, 2026 | Filing ID: 000085

Director Hurtsellers Christine 🟢 acquired 17.0K shares of AGNC Investment Corp. (AGNC) Transaction Date: Apr 16, 2026 | Filing ID: 000087

New Form 4/A - Pennant Group, Inc. <b>Filed:</b> 2026-04-17 <b>AccNo:</b> 0001766400-26-000041 <b>Size:</b> 7 KB

Izquierdo Sabido Agustin 🔴 sold 45 shares of LyondellBasell Industries N.V. (LYB) at $73.13 Transaction Date: Apr 15, 2026 | Filing ID: 000008

Revolution Medicines Announces Closing of Concurrent Upsized Public Offerings with Aggregate Gross Proceeds of Approximately $2.2 Billion, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares